Advertisement
After adjusting for inflation

Price Increases Larger for Older Cancer Drugs Than Newer Ones

0
Older meds rose 22.7 percent in price, compared to a 6.2 percent increase for newer treatments
The United States lags behind other advanced nations when it comes to infant mortality and the life expectancy of its citizens

Global Burden of Disease Report Evaluates the World’s Health

0
Life expectancy in the United States trails other wealthy nations
An experimental drug -- a vasopressin antagonist called ABT-436 -- shows some promise in treating alcohol use disorder and smoking

New Drug for Alcohol Use Disorder Appears Promising

0
Smokers may also benefit, results of a clinical trial suggest
Electronic-cigarette devices are randomly and unexpectedly exploding

Burns, Blast Injuries on the Rise From Exploding E-Cigarettes

0
Users say they're unaware the lithium batteries are a potential fire hazard
Dermatologists receive considerable payments

Dermatologists Receive Considerable Industry Payments

0
Variation in nature and amount of payments, with top 1 percent of doctors receiving at least $93,622
Empirical treatment with micafungin seems not to increase invasive fungal infection-free survival at 28 days for patients with intensive care unit-acquired sepsis with Candida colonization

Empirical Micafungin Treatment Doesn’t Improve Survival

0
No increase in invasive fungal infection-free survival for ICU-acquired sepsis, Candida colonization
The U.S. Drug Enforcement Administration says it has mandated significant cuts in the production of Schedule II opiate and opioid medication.

DEA Planning to Cut Production of Opioid Medication

0
There will be a reduction in amount of opioid controlled substances manufactured in 2017
The measles outbreak that occurred in an Amish community in 2014 illustrates the ongoing threat the infection presents -- and the importance of routine vaccination

CDC Reviews Measles Outbreak in Amish Community

0
Nearly all who were infected had not been vaccinated, researchers say
For antipsychotic-treated obese patients with schizophrenia

Exenatide Does Not Promote Weight Loss in Schizophrenia

0
No significant difference in weight loss for obese patients treated with exenatide, placebo
Weekly doses of vitamin D do not improve oral glucose tolerance or markers of glycemic status among those at risk for diabetes

Vitamin D Doesn’t Improve Glucose Measures

0
However, significant improvement in LDL cholesterol seen in those with diabetes risk